All U.S. sources
| Title | Link |
|---|---|
| RCT - Research Corporation Technologies - home page - "an independent technology management company that provides value-adding commercialization services to academia and industry" | http://www.rctech.com/ |
| International Business Incubator - home page - "designed to be a first home for international companies expanding to the US for the first time" | http://www.ibi-sv.org/ |
| National Business Incubation Association - home page - "provides thousands of professionals with the information, education, advocacy and networking resources to bring excellence to the process of assisting early-stage companies" | http://www.nbia.org/ |
| Pamela J. Goodwin and al. - The Effect of Group Psychosocial Support on Survival in Metastatic Breast Cancer - New England Journal of Medicine - Volume 345:1719-1726 December 13, 2001 Number 24 | http://content.nejm.org/cgi/content/short/345/24/1719?query=TOC |
| John H. Krystal - Naltrexone in the Treatment of Alcohol Dependence - New England Journla of Medicine - Volume 345:1734-1739 December 13, 2001 Number 24 - abstract | http://content.nejm.org/cgi/content/short/345/24/1734?query=TOC |
| Schering-Plough - home page | http://www.schering-plough.com/ |
| ICOS - home page - | http://www.icos.com/ |
| Darden - University of Virginia - Genzyme/Geltex pharmaceuticals joint venture- - (do not copy status) - (15 pages) | http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID200849_code991214200.pdf?abstractid=200849 |
| Sara
F. Ellison & Christopher M. Snyder - COUNTERVAILING POWER IN
WHOLESALE PHARMACEUTICALS MIT - Department of Economics - Working Paper 01-27 - July 2001 - (40 pages) |
http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID277290_code010725500.pdf?abstractid=277290 |
| Steve Bunk, Mind Body Research Matures, Mounting evidence prompts NIH to embrace a once-marginal field, The Scientist 15[12]:8, Jun. 11, 2001. | http://www.the-scientist.com/yr2001/jun/bunk_p8_0 |
| Brendan
A. Mahe, Chelation Advocates Get a Chance to Prove Their Mettle NIH puts up $30 million for an in-depth look at a controversial therapy, The Scientist 15[12]:33, Jun. 11, 2001, PROFESSION |
http://www.the-scientist.com/yr2001/jun/prof1_010 |
| Marcia Angell & Jerome P. Kassirer, Alternative Medicine -- The Risks of Untested and Unregulated Remedies, The New England Journal of Medicine -- September 17, 1998 -- Vol. 339, No. 12 , Editorial. | http://content.nejm.org/cgi/content/full/339/12/839 |
| Stephen Barrett, A Close Look at Naturopathy | http://www.quackwatch.com/01QuackeryRelatedTopics |
| Stephen
Barrett, A Few Thoughts on Ayurvedic Mumbo-Jumbo, Quackwatch, . |
http://www.quackwatch.com/04ConsumerEducation/cho |
| Saul Green, Chelation Therapy: Unproven Claims and Unsound Theories, Quackwatch. | http://www.quackwatch.com/01QuackeryRelatedTopics |
| Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL, Unconventional medicine in the United States. Prevalence, costs, and patterns of use, N Engl J Med 1993 Jan 28;328(4):246-52, | http://content.nejm.org/cgi/content/full/328/4/246 |
| NCAHF - Position Paper on Over-the Counter Herbal Remedies - 1995 | http://www.ncahf.org/pp/herbal.html |
| Isadora Stehlin, Homeopathy: Real Medicine or Empty Promises? FDA Consumer magazine (December 1996). | http://www.fda.gov/fdac/features/096_home.html |
| David W. Ramey, Mahlon Wagner, Robert H. Imrie, Victor Stenger, Homeopathy and Science: A Closer Look, | http://www.phys.hawaii.edu/vjs/www/med/homeop.htm |
| Stephen Barrett, Homeopathy: The Ultimate Fake, Quackwatch | http://www.quackwatch.com/01QuackeryRelatedTopics |
| NCAHF - Position Paper on Homeopathy | http://www.ncahf.org/pp/homeop.html |
| Oliver Wendell Holmes - Homeopathy and Its Kindred Delusions | http://www.quackwatch.com/01QuackeryRelatedTopics |
| Committee on Transgenic Nomenclature, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Standardized Nomenclature for Transgenic Animals, ILAR News Vol 34(4) -- 1992 | http://www4.nas.edu/cls/ijhome.nsf/44bf87db309563 |
| Integrity in Science, Non profit organizations with ties to the industry, a CSPI Project | http://www.cspinet.org/integrity/corp_funding.htm |
| European Aids Treatment Group (EATG), Glaxo SmithKline Delivers Killer Greed- In Time for the Holidays | http://www.eatg.org/news/00/271200.html#greed |
| Kate Schiel, the war on cancer is a fraud, Disinformation, May 13, 2001 | http://www.disinfo.com/pages/dossier/id336/pg1/ |
| U.S. Federal Drug and Food Administration - FDA - home page | http://www.fda.gov/guidance |
| NCAHF Position Paper on Acupuncture (1990 | http://www.ncahf.org/pp/acu.html |
| NIH Consensus Statement on Acupuncture (n° 107), | http://odp.od.nih.gov/consensus/cons/107/107_statement.htm |
| Stephen Barrett, Acupuncture, Qigong, and "Chinese Medicine", | http://www.quackwatch.com/01QuackeryRelatedTopics |
| FTC - Miracle health Claims, Add a Dose of Skeptici | http://www.ftc.gov/bcp/conline/pubs/health/frdhea |
| Kathi J Kemper Complementary and Alternative M | http://www.ewjm.com/cgi/content/full/174/4/272 |
| National Center for Complementary and Alternative Medicine, Annual Report 2000 | http://nccam.nih.gov/an/annual-report/nccam2000.pdf |
| Consensus Statement, Integration of Behavioral and Relaxation Approaches Into the Treatment of Chronic Pain and Insomnia, National Institutes of Health, | http://text.nlm.nih.gov/nih/ta/www/17.html |
| Home Page of the Center for Drug Evaluation and Research (FDA) - home page | http://www.fda.gov/cder/ |
| List of Guidance Documents of CDER | http://www.fda.gov/cder/guidance/index.htm |
| Center for Drug Evaluation and Research, 2000 Report to the Nation Improving Public Health Through Human Drugs | http://www.fda.gov/cder/reports/RTN2000/RTN2000.P |
| Center for Drug Evaluation and Research, CDER 1999 Report to the Nation Improving Public Health Through Human Drugs | http://www.fda.gov/cder/reports/rtn99.pdf |
| CDER, 1997 Report to the Nation: Improving Public Health Through Human Drugs | http://www.fda.gov/cder/reports/rptntn97.pdf |
| FDA Center for Food Safety and Applied Nutrition, Cosmetic Handbook | http://www.cfsan.fda.gov/~dms/cos-hdbk.html |
| Home Page of the FDA Center for Food Safety & Applied Nutrition | http://www.cfsan.fda.gov |
| Home Page of the FDA Center for Food Safety & Applied Nutrition regarding cosmetics | http://vm.cfsan.fda.gov/~dms/cos-toc.html |
| Home Page of the Health Research Group of Public Citizen | http://www.citizen.org/hrg/index.cfm |
| Health Research Group: list of information on Dietary and Herbal Supplements | http://www.citizen.org/hrg/drugs/articles.cfm?ID= |
| E-Letter on Drugs for Severe Psychiatric Illnesses, Public Citizen | http://www.citizen.org/eletter/# |
| Medscape - home page | http://www.medscape.com/ |
| The Scientist - home page | http://www.the-scientist.com |
| The New England Journal of Medicine - home page | http://www.nejm.org/JHome.htm |
| Food and Drug Law Journal, Online Articles and Abstracts | http://www.fdli.org/pubs/Journal%20Online/journal |
| Washington Post, The Body Hunters, | http://www.washingtonpost.com/wp-dyn/world/issues |
| New York Times, Health Index | http://www.nyt.com/pages/health/index.html |
| Aegis - home page | http://www.aegis.com/ |
| Edward M. Basile, Ellen Armentrout & Kelly N. Reeves, Medical Device Labeling and Advertising: An Overview, 54 Food and Drug Law Journal 519-534 (1999) - (16 pages) | http://www.fdli.org/pubs/Journal%20Online/54_4/art2.pdf |
| J. Howard Beales III, Modification and Consumer Information: Modern Biotechnology and the Regulation of Information, 55 Food and Drug Law Journal 105-118 (2000) - (14 pages) | http://www.fdli.org/pubs/Journal%20Online/55_1/art6.pdf |
| Eric M. Blumberg, Abbott Laboratories Consent Decree and Individual Responsibility Under the Federal Food, Drug, and Cosmetic Act, 55 Food and Drug Law Journal 145-150 (2000) - (6 pages) | http://www.fdli.org/pubs/Journal%20Online/55_1/art9.pdf |
| Robert A. Book, Public Research Funding and Private Innovation: The Case of the Pharmaceutical Industry, December 2000 - (72 pages) | http://home.uchicago.edu/~rabook/Book_PharmInnov.pdf |
| Alan Sager, Deborah Socolar, Cutting Prescription Drug Spending by Paying Federal Supply Schedule Prices - Boston University - August 2000 - (49 pages) | http://dcc2.bumc.bu.edu/hs/sager/Cutting%20Rx%20prices%20in%208%20northeast%20states%202%20Aug%2000.pdf |
| CenterWatch - home page - "We provide information services used by patients, pharmaceutical, biotechnology and medical device companies, CROs and research centers involved in clinical research around the world" | http://www.centerwatch.com |
| American Medical News - home page | http://www.ama-assn.org/public/journals/amnews/amnews.htm |
| U.S. Federal Trade Commission - home page | http://www.ftc.gov/ |
| U.S. Department of Justice - home page | http://www.usdoj.gov/ |
| PubMed - search page - ("PubMed, a service of the National Library of Medicine, provides access to over 11 million MEDLINE citations back to the mid-1960's and additional life science journals. ") | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi |
| Program on the Pharmaceutical Industry - MIT Sloan School of Management - Cambridge, Massachusetts | http://web.mit.edu/popi/ |
| Corey A. Salsberg - Resurrecting the Woolly Mammoth: Science, Law, Ethics, Politics, and Religion - 2000 STAN. TECH. L. REV. 1 - Stanford University - | http://stlr.stanford.edu/STLR/Articles/00_STLR_1/index.htm |
| Gary Edmond and David Mercer - Trashing "Junk Science" - 1998 STAN. TECH. L. REV. 3 - Stanford University | http://stlr.stanford.edu/STLR/Articles/98_STLR_3/index.htm |
| Jennifer Kulynych- Intent to Deceive: Mental State and Scienter in the New Uniform Federal Definition of Scientific Misconduct - 1998 STAN. TECH. L. REV. 2 - Stanford University | http://stlr.stanford.edu/STLR/Articles/98_STLR_2/index.htm |
| John H. Barton - Competition and Competitive Uses of Intellectual Property - Symposium Paper - (do not cite status) - Stanford University | http://stlr.stanford.edu/STLR/Symposia/Antitrust/index.htm |
| Ashish Arora and Andrea Fosfuri - Licensing in the Chemical Industry - Symposium Paper - (Do not cite status) - April 1998 - Stanford University | http://stlr.stanford.edu/STLR/Symposia/Antitrust/index.htm |
| John H. Barton - The Impact of Contemporary Patent Law on Plant Biotechnology Research - Symposium Paper - (Do not cite status) | http://stlr.stanford.edu/STLR/Symposia/Antitrust/index.htm |
| Mark A. Lemley - Ration Ignorance at the Patent Office - Essay - Northwestern University Law Review Vol.95 n° 4 - Working Paper from Berkeley web site- 2001 - (39 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/101.pdf |
| John R. Allison & Mark A. Lemley - The Growing Complexity of the United States Patent System - Working Paper from Berkeley web site - 2001 - (84 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/201.pdf |
| Richard J. Gilbert and Willard K. Tom - Is Innovation King at the Antitrust Agencies?: The Intellectual Property Guidelines Five Years Later - April 2001 - Working paper from Berkeley web site - (47 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/601.pdf |
| Matthew J. Conigliaro, Andrew C. Greenberg & Mark A. Lemley - Foreseeability in patent law - Working paper from Berkeley web site - 2001 - (34 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/701.pdf |
| Pfizer - home page | http://www.pfizer.com/main.html |
| Merck - home page | http://www.merck.com/ |
| Merck - The Merck Manual of Medical Information--Home Edition | http://www.merck.com/pubs/mmanual_home/contents.htm |
| Tufts Center for the Study of Drug Development | http://www.tufts.edu/med/csdd/index.html |
| Tufts Center, Outlook 2001 - (12 pages) | http://www.tufts.edu/med/csdd/images/otlk2001.pdf |
| Tufts Center - A Methodology for Counting Costs for Pharmaceutical R&D - November 30, 2001 - (4 pages) | http://www.tufts.edu/med/csdd/images/StudyMethodology.pdf |
| Biotechnology Industry Organization - home page | http://www.bio.org/ |
| BIO - Genomics - PRIMER: GENOME AND GENETIC RESEARCH, PATENT PROTECTION AND 21 st CENTURY MEDICINE - July 2001 | http://www.bio.org/genomics/primer.html |
| BIO - Statement on patent-term amendments to protect diligent patent applicants and 18-month publication of patent applications before the Courts and Intellectual Property Subcommittee | http://www.bio.org/laws/tstm2261.html |
| BIO - Guide on biotechnology - (120 pages) | http://www.bio.org/aboutbio/guide2001/letter.pdf |
| DIA - Drug Information Association - home page | http://www.diahome.org |
| FIM - The Foundation For Innovation In Medicine - home page - "a nonprofit foundation dedicated to increasing medical research and discovery concentrating particularly on natural substances be they pharmaceuticals or nutraceuticals" | http://www.fimdefelice.org/ |
| Michelle Stacey - Eating Your Medicine - The Battle Over Superfoods, a chapter refering to Stephen L. DeFelice | http://www.fimdefelice.org/books.consumed4.html |
| PharmWeb - "the premier online community of pharmaceutical and healthcare-related professionals with approximately 25,000 self-registered users" | http://www.pharmweb.net/ |
| FDA, Acupuncture needle status changed - April 1, 1996 | http://www.fda.gov/bbs/topics/ANSWERS/ANS00722.html |
| FDA, Devices classification - previous correspondance | http://www.fda.gov/cdrh/devadvice/21.html#contents |
| FDA - Product Code Classification Database | http://www.fda.gov/cdrh/prodcode.html |
| FDA - Good Manufacturing Practices (GMP) / Quality System (QS) Regulation | http://www.fda.gov/cdrh/devadvice/32.html#contents |
| FDA - CDRH Annual Report Fiscal Year 2000 | http://www.fda.gov/cdrh/annual/fy2000/annualreport-2000.pdf |
| FDA - Breast Implants - An Information Update - 2000 - (82 pages) | http://www.fda.gov/cdrh/breastimplants/indexbip.PDF |
| FDA - Investigation of Human Health Effects Associated with Potential Exposure to Genetically Modified CornJune 11, 2001 - (24 pages) | http://www.cdc.gov/nceh/ehhe/Cry9cReport/cry9creport.pdf |
| FDA - FDA documents concerning StarLink | http://www.epa.gov/scipoly/sap/index.htm#july |
| FDA - Food and Cosmetic Guidance Documents | http://www.cfsan.fda.gov/~dms/guidance.html |
| FDA - Guidance for Industry - Significant Scientific Agreement in the Review of Health Claims for Conventional Foods and Dietary Supplements | http://www.cfsan.fda.gov/~dms/ssaguide.html |
| FDA - Draft - Guidance for Industry - Voluntary Labeling Indicating Whether Foods Have or Have Not Been Developed Using Bioengineering - January 2001 | http://www.cfsan.fda.gov/~dms/biolabgu.html |
| FDA - Report on Consumer Focus Groups on Biotechnology | http://www.cfsan.fda.gov/~comm/biorpt.html |
| FDA - Food and Cosmetics International Activities | http://www.cfsan.fda.gov/~comm/intl-toc.html |
| FDA - A New Kind of Fish Story: The Coming of Biotech Animals - FDA Magazine - January February 2001 | http://www.cfsan.fda.gov/~dms/fdbiofsh.html |
| FDA - Dietary supplements - home page | http://www.cfsan.fda.gov/~dms/supplmnt.html |
| FDA - Overview of Dietary Supplements - FAQs | http://www.cfsan.fda.gov/~dms/supplmnt.html |
| FDA - Claims That Can Be Made for Conventional Foods and Dietary Supplements | http://www.cfsan.fda.gov/~dms/hclaims.html |
| FDA - A Food Labeling Guide--Appendix C | http://www.cfsan.fda.gov/~dms/flg-6c.html |
| FDA - CFR 21 § 101.72 - Health claims: calcium and osteoporosis. | http://www.cfsan.fda.gov/~lrd/cf101-72.html |
| FDA - Bovine Spongiform Encephalopathy (BSE) | http://www.fda.gov/cber/bse/bse.htm |
| FDA - CBER Guidances / Guidelines / Points to Consider | http://www.fda.gov/cber/guidelines.htm |
| FDA - CBER - Blood Publications | http://www.fda.gov/cber/blood/bldpubs.htm |
| FDA - CBER - Tissue Related Documents | http://www.fda.gov/cber/tissue/docs.htm |
| Advertising Law Resource Center - home page | http://www.lawpublish.com |
| Erik Bierbauer - Liquid Honesty: The first Amendment Right to Market the Health Benefits of Moderate Alcohol Consumption - Ney York University Law Review - Vol. 74:1057 - (42 pages) | http://www.nyu.edu/pages/lawreview/74/4/bierbauer.pdf |
| Merrill Matthews - Prices, Profits and Prescriptions: The Pharmatech Industry in the New Economy - December 2001 | http://www.washingtonpolicy.org/HealthCare/PBMatthewsDrugPrices.html |
| Washington Legal Foundation - home page - defends principles such as "individual freedom, limited government, free market economy, and a strong national security and defense" | http://www.wlf.org/ |
| Washington Legal Foundation - Health Projects | http://www.wlf.org/Litigating/litprojects.asp?detail=3 |
| FDA - Food Labeling; Health Claims and Label Statements for Dietary Supplements - Strategy for Implementation of Pearson Court Decision | http://www.fda.gov/ohrms/dockets/98fr/120199b.pdf |
| NFPA Letter to FDA Commissioner Dr. Jane Henney Regarding FDA's Position on Pearson v. Shalala - April 4, 2000 | http://www.nfpa-food.org/Letters/fdapearson00_4_4.html |
| Pearson v. Shalala - January 15, 1999 | http://www.emord.com/fdadecision.htm |
| Pearson v. Shalala - Memorandum Opinion - (38 pages) | http://www.emord.com/Memo%20Opinion%202-2-011.pdf |
| David C. Vladeck , Devaluing Truth: Unverified Health Claims in the Aftermath of Pearson v. Shalala, 54 Food and Drug Law Journal at 535 - (20 pages) | http://www.fdli.org/pubs/Journal%20Online/54_4/art3.pdf |
| John Kamp, Daniele Troy, Elizabeth Alexander - FDA Marketing v. First Amendment: Washington Legal Foundation Legal Challenges to Off-Label Policies May Force Unprecedented Changes at FDA - 54 Food and Drug Law Journal - (12 pages) | http://www.fdli.org/pubs/Journal%20Online/54_4/art4.pdf |
| U.S. DC Circuit Court of Appeals - Pearson Durk V. FDA -January 1999 | http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl?court=DC&navby=case&no=985043A |
| Richard F. Kingham and Grant H. Castle - Data and Marketing Exclusivity for Pharmaceuticals in the European Community - 55 Food and Drug Law Journal 209 - (16 pages) | http://www.fdli.org/pubs/Journal%20Online/55_2/art3.pdf |
| Patrice Trouiller, Els Torreele, Piero Olliaro, Nick White, Susan Foster, Dyann Wirth and Bernard Pecoul - Drugs for neglected diseases: a failure of the market and a public health failure? - Tropical Medicine and International Health - November 2001 | http://www.neglecteddiseases.org/tmih.pdf |
| FDA - Participation of Racial/Ethnic Groups in Clinical Trials and Race-Related Labeling: A Review of New Molecular Entities Approved 1995-1999 - | http://www.fda.gov/cder/reports/race_ethnicity/race_ethnicity_report.htm |
| GreenPeace - True Food Network - home page | http://www.truefoodnow.org |
| Technology Review - Biotech - home page - "An MIT enterprise" | http://www.technologyreview.com/biotech.asp |
| New Scientist.com | http://www.newscientist.com/ |
| Deepak Somaya & David J. Teece - Combining Patented Inventions in Multi-invention Products: Transactional Challenges and Organizational Choices - Working paper from Berkeley web site - August 2001 - (49 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/wp/801.pdf |
| Janice M. Mueller, The Evoling application fo the written description requirement to biotechnology inventions - Berkeley Technology Law Journal- Issue 13:2 - 1998 | http://www.law.berkeley.edu/journals/btlj/articles/13_2/Mueller/html/reader.html |
| Robert Heidt - Maintaining incentives for bioprospecting: the occasional need for a right to lie - Berkeley Technology Law Journal - issue: 13:2 - 1998 | http://www.law.berkeley.edu/journals/btlj/articles/13_2/Heidt/html/reader.html |
| Lawrence B. Landman - Did Congress Actually Create Innovation Markets? - Berkeley Technology Law Journal - Issue 13:2 - 1998 - | http://www.law.berkeley.edu/journals/btlj/articles/13_2/Landman/html/reader.html |
| U.S. Department of Justice and the Federal Trade Commission - Antitrust Guidelines for the Licensing of Intellectual Property - April 1996 | http://www.usdoj.gov/atr/public/guidelines/ipguide.htm |
| Department of Justice and Federal Trade Commission - Statements of antitrust enforcement policy in health care | http://www.ftc.gov/reports/hlth3s.htm |
| FTC Antitrust Actions in health care services and products - June 2001 | http://www.ftc.gov/bc/hcindex/hcupdate.pdf |
| FTC
- Analysis to Aid Public Comment - proposed consent order with Hoechst
Marion Roussel, Inc. (“HMR”), Carderm Capital, L.P. (“Carderm”), and Andrx Corporation (“Andrx”) - (7 pages9 |
http://www.ftc.gov/os/2001/04/hoechstanalysis.pdf |
| FTC - Complaint - against Schering-Plough Corporation, Upsher-Smith Laboratories, American Home Products Corporation, | http://www.ftc.gov/os/2001/04/scheringpart3cmp.pdf |
| FTC - Antitrust Guidelines for Collaborations Among Competitors - April 2000 - (39 pages) | http://www.ftc.gov/os/2000/04/ftcdojguidelines.pdf |
| FTC - Marketer of Herbal Supplement Products Agrees to Settle FTC Charges That Safety and Health Benefit Claims Were False | http://www.ftc.gov/opa/2001/12/chrisenterprises2.htm |
| FTC - Statement of the Federal Trade Commission's Bureau of Consumer Protection On the National Cancer Institute's Report on Cigarette Testing Method - November 27, 2001 | http://www.ftc.gov/opa/2001/11/ncistudy.htm |
| FTC - Statement of Susan A. Creighton, Deputy Director, Bureau of Competition Regarding FTC Settlement with Hearst Corporation - November 20, 2001 - news release | http://www.ftc.gov/opa/2001/11/hearst.htm |
| FTC - Five Manufacturers of Over-the-Counter Analgesic Products Agree to Settle Charges of Mislabeling Certain Products as "Made in USA" - November 6, 2001 - press release | http://www.ftc.gov/opa/2001/11/musa.htm |
| FTC -FTC Staff Comments on FDA’s Plans to Collect Information on Direct-To-Consumer Prescription Drug Advertising - September 24, 2001 - | http://www.ftc.gov/be/v010008.htm |
| Dennis Murphy, Theodore H. Hoppock and Michelle K. Rusk - A Generic Copy Test of Food Health Claims in Advertising - November 1998 | http://www.ftc.gov/os/1998/9811/netfood.pdf |
| Bureau of Economics with the Bureau of Competition and the Bureau of Consumer Protection - Competition and the Financial Impact of the Proposed Tobacco Industry Settlement - September 1997 | http://www.ftc.gov/reports/tobacco/ndoc95.pdf |
| FTC - Dietary Supplements: An Advertising Guide for Industry - (32 pages) | http://www.ftc.gov/bcp/conline/pubs/buspubs/dietsupp.pdf |
| FTC - Enforcement Policy Statement on Food Advertising - May 1994 | http://www.ftc.gov/bcp/policystmt/ad-food.htm |
| FTC - List of documents on tobacco | http://www.ftc.gov/bcp/menu-tobac.htm |
| Richard S. Strauss & Harold A. Pollack - Epidemic Increase in Childhood Overweight, 1986-1998 - JAMA 2001;286:2845-2848 | http://jama.ama-assn.org/issues/v286n22/abs/jbr10287.html |
| Charles H. Chesnut III - Osteoporosis, an Underdiagnosed Disease - JAMA 2001 | http://jama.ama-assn.org/issues/v286n22/ffull/jed10078.html |
| Cigarette Smoking Among AdultsUnited States, 1999 - JAMA 2001 | http://jama.ama-assn.org/issues/v286n22/ffull/jwr1212-2.html |
| U.S. Patent and Trademark Office - PCT Administrative Instructions - (85 pages) | http://www.uspto.gov/web/offices/pac/dapps/pct/pctadmin.pdf |
| U.S. Patent and Trademark Office - Provisional patents information | http://www.uspto.gov/web/offices/pac/provapp.htm |
| US Patent and Trademark Office - Manual of Patent Examining Procedure | http://www.uspto.gov/web/offices/pac/mpep/mpep_e8_pdfs_zipped.zip |
| US Patent and Trademark Office - list of cases in alphabetical order | http://www.uspto.gov/web/offices/com/sol/foia/bpai.htm |
| US Patent and Trademark Office - Changes to Implement 20-Year Patent Term and Provisional Applications - June 1995 | http://www.uspto.gov/web/offices/com/doc/uruguay/20_year_term.html |
| Patent and Trademark Office Report on Recommendations from the April 1998 Conference on Database Protection and Access Issues - July 1998 | http://www.uspto.gov/web/offices/dcom/olia/dbconf/dbase498.htm |
| United States Patent and Trademark Office - Eighteen-Month Publication of Patent Applications | http://www.uspto.gov/web/offices/pac/pgpub.htm |
| U.S. Patent and Trademark Office - Fee Schedule | http://www.uspto.gov/web/offices/ac/qs/ope/1999/fee20011001.htm |
| US Patent and Trademark Office - Patent Search | http://www.uspto.gov/patft/index.html |
| Drug Enforcement Agency - Schedules of controlled substances | http://www.usdoj.gov/dea/pubs/schedule.pdf |
| US Drug Enforcement Administration - DEA - Information about Ritalin / Methylphenidate | http://www.usdoj.gov/dea/concern/abuse/chap4/stimula/methylph.htm |
| US Drug Enforcement Administration - DEA - Information about Anorectic Drugs | http://www.usdoj.gov/dea/concern/abuse/chap4/stimula/anorecti.htm |
| US Department of Justice - Tobacco news | http://www.usdoj.gov/civil/cases/tobacco/index.htm |
| CBO - The Proposed Tobacco Settlement: Issues from a Federal Perspective, April 1998 | http://www.cbo.gov/showdoc.cfm?index=407&sequence=0&from=1 |
| John Y. Chai, Medical Device Regulation in the United States and the European Union: A Comparative Study, 55 Food and Drug Law Journal 57-80 (2000), | http://www.fdli.org/pubs/Journal%20Online/55_1/art4.pdf |
| Ian M. Cockburn, Rebecca Henderson and Scott Stern, The Diffusion of Science Driven Drug Discovery: Organizational Change in Pharmaceutical Research, September 1999 | http://www2.cid.harvard.edu/cidbiotech/events/Hend2.pdf |
| Ian Cockburn, Rebecca Henderson and Scott Stern, Balancing Incentives: The Tension Between Basic and Applied Research, August 2000, | http://webuser.bus.umich.edu/departments/busecon/research/papers/BalanceSep00.pdf |
| Rochelle Cooper Dreyfuss, Collaborative Research: Conflicts on Authorship, Ownership, and Accontability, 53 Vand. L. Rev. 1055-1388 (May 2000) | http://law.vanderbilt.edu/lawreview/vol534/dreyfuss.pdf |
| H.E. Frech III and Richard D. Miller Jr., The Productivity of Health Care and Pharmaceuticals: An International Comparison, December 1996, -do not quote status- (67 pages) | http://www.econ.ucsb.edu/papers/health.pdf |
| Jeffrey L. Furman, Firm effects vs. Location effects in the organization of pharmaceutical research, January 2001, | http://web.mit.edu/jfurman/www/firm%20v%20industry%20effects%20-%20draft%20Jan01.pdf |
| GAO - Adverse Drug Events, The Magnitude of Health Risk Is Uncertain Because of Limited Incidence Data, GAO report, January 2000 | http://www.gao.gov/archive/2000/he00053t.pdf |
| ·GAO - Adverse Events: Surveillance Systems for Adverse Events and Medical Errors, February 2000, | http://www.gao.gov/archive/2000/he00061t.pdf |
| GAO - Attention Disorder Drugs Few Incidents of Diversion or Abuse Identified by Schools, September 2001, | http://www.gao.gov/new.items/d011011.pdf |
| GAO - Dietary Supplements: Uncertainties in Analyses Underlying FDA's Proposed Rule on Ephedrine Alkaloids, July 1999, | http://www.gao.gov/archive/1999/h299090.pdf |
| GAO - Drug Abuse: Efforts Under Way to Determine Treatment Outcomes, February 2000 | http://www.gao.gov/archive/2000/he00060t.pdf |
| GAO - Drug Safety: Most Drugs Withdrawn in Recent Years Had Greater Health Risks for Women, January 2001 | http://www.gao.gov/new.items/d01286r.pdf |
| GAO - Health Products for Seniors: Potential Harm From "Anti-Aging" Products, September 2001, | http://www.gao.gov/new.items/d011139t.pdf |
| GAO - Human Fetal Tissue: Acquisition for Federally Funded Biomedical Research, October 2000, | http://www.gao.gov/archive/2000/d010065r.pdf |
| GAO - Human Subjects Research: HHS Takes Steps to Strengthen Protections, But Concerns Remain, May 2001 | http://www.gao.gov/new.items/d01775t.pdf |
| GAO - Mutual Recognition Agreement: Update on the Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Good Manufacturing Practice Regulatory Systems, August 1999 | http://161.203.16.4/paprpdf2/162604.pdf |
| GAO - Mutual Recognition Agreement: Food and Drug Administration's Progress in Assessing Equivalency of European Union Pharmaceutical Inspection Programs, February 1999 | http://161.203.16.4/paprpdf2/161744.pdf |
| GAO - NIH Clinical Trials: Various Factors Affect Patient Participation, October 1999 | http://www.gao.gov/archive/1999/he99182.pdf |
| GAO - NIH Research: Improvements Needed in Monitoring Extramural Grants, May 2000 | http://www.gao.gov/archive/2000/h100139.pdf |
| Rebecca Henderson, Luigi Orsenigo, Gary P. Pisano, The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions between Scientific, Institutional and Organizational Change, April 1998, | http://www2.cid.harvard.edu/cidbiotech/events/Hend1.pdf |
| GAO - Women's Health: Women Sufficiently Represented in New Drug Testing, but FDA Oversight Needs Improvement, July 2001, | http://www.gao.gov/new.items/d01754.pdf |
| GAO - ·Women's Health: NIH Has Increased Its Efforts to Include Women in Research, May 2000, | http://www.gao.gov/archive/2000/he00096.pdf |
| GAO - Vaccine Injury Trust Fund: Revenue Exceeds Current Need for Paying Claims, March 2000, | http://www.gao.gov/archive/2000/he00067.pdf |
| GAO - Prescription Drugs, Many Factors Affected FDA's Approval of Selected 'Pipeline' Drugs, August 2000, | http://www.gao.gov/archive/2000/he00140.pdf |
| GAO - Prescription Drugs: Drug Company Programs Help Some People Who Lack Coverage, November 2000 | http://www.gao.gov/new.items/d01137.pdf |
| GAO - Pediatric Drug Research: Substantial Increase in Studies of Drugs for Children, But Some Challenges Remain, May 2001, | http://www.gao.gov/new.items/d01705t.pdf |
| Cass R. Sunstein - Social and Economic Rights? Lessons from South Africa ? - Working Paper - n° 12 - (page 17) | http://www.law.uchicago.edu/academics/publiclaw/resources/12.CRS.pdf |
| Social Science Research Network - SSRN - home page - "devoted to the rapid worldwide dissemination of social science research" | http://www.ssrn.com/ |
| William W. Fisher III - Professor of Law, Harvard University Harvard- bioprospecting - Works in Progress - in Legal Reform in Central America (forthcoming, Harvard University Press, 2000) | http://www.law.harvard.edu/Academic_Affairs/coursepages/tfisher/bioprospecting.html |
| William W. Fisher III - The Growth of Intellectual Property: A History of the Ownership of Ideas in the United States - Harvard University - Eigentum im internationalen Vergleich (Vandenhoeck & Ruprecht, 1999), 265-91 | http://www.law.harvard.edu/Academic_Affairs/coursepages/tfisher/iphistory.html |
| William W. Fisher III - The Impact of “Terminator Gene” Technologies on Developing Countries - Report to the UK Department for International Development, December 1999 - Harvard University | http://www.law.harvard.edu/Academic_Affairs/coursepages/tfisher/terminator.html |
| Dror
Ben-Asher - In Need of Treatment ? Merger Control, Pharmaceutical
Innovationn & Consumer Welfare - Discussion Paper No. 270 12/99 - Harvard Law School - (110 pages) |
http://www.law.harvard.edu/programs/olin_center/papers/pdf/270.pdf |
| A Pharmacist's Guide to Generic Companies - Click on First Letter of Company You are Searching For | http://www.pharmacytimes.com/generic.html |
| Drug Benefit Trends - Medscape | http://www.medscape.com/SCP/DBT/public/journal.DBT.html |
| Kaiser Network - home page | http://www.kaisernetwork.org/index.cfm |
| Kaiser Family Foundation - home page - "an independent, national health philanthropy dedicated to providing information and analysis on health issues to policymakers, the media, and the general public" | http://www.kff.org/ |
| Kaiser Family Foundation - Generation Rx.com How Young People Use the Internet for Health Information - December 2001 - (45 pages) | http://www.kff.org/content/2001/20011211a/GenerationRx.pdf |
| Kaiser Family Foundation - Understanding the Effects of Direct-to-Consumer Prescription Drug Advertising -November 2001 - (26 pages) | http://www.kff.org/content/2001/3197/DTC%20Ad%20Survey.pdf |
| Functional Foods for Health - home page - "a joint program of the University of Illinois at Chicago and the University of Illinois at Urbana-Champaign" | http://www.ag.uiuc.edu/~ffh/ |
| Institute of Food Technologists - home page - "a nonprofit scientific society with 28,000 members working in food science, food technology, and related professions in industry, academia and government" | http://www.ift.org/ |
| IFT Expert Report on Biotechnology and Foods - August 2000 - (56 pages) | http://www.ift.org/govtrelations/biotech/report.pdf |
| American Dietetic Association - Biotechnology and the future of food -- Position of ADA | http://www.eatright.org/abiotechnology.html |
| CAST - Biotechnology Communications | http://www.cast-science.org/biotechnology/index.html |
| United States Department of Agriculture (USDA) - Agricultural Biotechnology | http://www.aphis.usda.gov/biotechnology/index.html |
| U.S. Environmental Protection Agency - EPA - home page | http://www.epa.gov/ |
| National Academy of Sciences - Transgenic Plants and World Agriculture - (46 pages) | http://bob.nap.edu/html/transgenic/pdf/transgenic.pdf |
| National Academy of Sciences (NAS) - home page - "private, non-profit, self-perpetuating society of distinguished scholars engaged in scientific and engineering research, dedicated to the furtherance of science and technology " | http://www4.nationalacademies.org/nas/nashome.nsf |
| The Unofficial Gleevec site - home page | http://www.newcmldrug.com/ |
| Gleevec unofficial support web site - home page | http://www.cmlsupport.com/cmlstiresourcecenter.htm |
| Gleevec official web site - home page | http://www.gleevec.com/ |
| Jane Wells et al. - Newspaper Reporting of Screening Mammography - Annals of Internal Medicine - December 18, 2001 - Vol. 135 - n° 12 - Pages 1029-1037 | http://www.annals.org/issues/v135n12/abs/200112180-00006.html |
| Kurt Kroenke - Similar Effectiveness of Paroxetine, Fluoxetine, and Sertraline in Primary Care: A Randomized Trial - JAMA - December 19, 2001 - Vol.286, n° 23 - | http://jama.ama-assn.org/issues/v286n23/rfull/joc10747.html |
| Amgen - home page | http://www.amgen.com/ |
| Genentech - home page | http://www.gene.com/ |
| Alza - home page | http://www.alza.com/ |
| Genzyme - home page | http://www.genzyme.com/welcome.htm |
| Chiron - home page | http://www.chiron.com/ |
| Johnson & Johnson - home page | http://www.jnj.com/ |
| Robert Blackburn - Extraterritorial enforcement - practical considerations for lawyers - (5 pages) | http://www.law.washington.edu/Casrip/Symposium/Number6/Blackburn.pdf |
| Millenium - home page | http://www.mlnm.com/ |
| International Intellectual Property Institute - IIPI - home page - "a nonprofit, nonpartisan organization dedicated to improving intellectual property systems around the world" | http://www.iipi.org/eng/ |
| IIPI - HIV/AIDS Pilot Project - To Deliver Patented Therapies & Other Treatments to Patients in Developing Countries - | http://www.iipi.org/eng/projects/aids.asp |
| American Bar Association ABA - Antitrust section | http://www.abanet.org/antitrust/home.html |
| American Bar Association - ABA - Health Law Section | http://www.abanet.org/health/home.html |
| American Bar Association ABA - Section of Intellectual Property Law | http://www.abanet.org/intelprop/home.html |
| Delphion - home page - "providing easy access to patent research, IP management and analytic tools that empower Fortune 1000 enterprises to strategically manage their intellectual property assets" | http://www.delphion.com/ |
| American Intellectual Property Law Association - AIPLA - home page | http://www.aipla.org/ |
| Foundation for Genetic Medicine - home page - examines "a host of issues such as those regarding genetic medicine, behavioral genetics, and the ethical, legal, and social features involved" | http://www.geneticmedicine.org |
| The Committee For the Protection of Human Subjects - homepage - University of California at Berkeley | http://cphs.berkeley.edu:7006/ |
| U.S. Code of Federal Regulations CFR - Title 45 - Public Welfare - Part 46 - Protection of human subjects | http://www.brown.edu/Administration/Research_Administration/OPRR/46index.html |
| Belmont Report - Ethical Principles and Guidelines for the Protection of Human Subjects of Research - April 18, 1979 | http://ohrp.osophs.dhhs.gov/humansubjects/guidance/belmont.htm |
| Jeffrey M. Perloff, Valerie Y. Suslow, and Paul J. Seguin - Higher Prices from Entry: Pricing of Brand-Name Drugs - Working Paper No. CPC99-03 - University of California at Berkeley - (39 pages) | http://www.haas.berkeley.edu/groups/cpc/WPs/99-3_are778.pdf |
| Jeanne Clark et al., USPTO - Patent Pools: A Solution to the Problem of Access in Biotechnology Patents? - December 2000 - (17 pages) | http://www.uspto.gov/web/offices/pac/dapp/opla/patentpool.pdf |
| Robert P. Merges - Institutions for Intellectual Property Transactions: The Case of Patent Pools August - 1999 Revision - (74 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/merges/pools.pdf |
| Robert P. Merges -As Many as Six Impossible Patents Before Breakfast: Property Rights for Business Concepts and Patent System Reform - University of California at Berkeley - (39 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/merges/siximp.pdf |
| Robert P. Merges - Property Rights Theory and the Commons: The Case of Scientific Research - 1996- Cambridge - (24 pages) | http://www.law.berkeley.edu/institutes/bclt/pubs/merges/rpmart4.pdf |
| U.S. National Institutes of Health (NIH), about NIH | http://www.nih.gov/about/ |
| FDA, Guidance for Institutional Review Boards and Clinical Investigators, 1998 Update | http://www.fda.gov/oc/ohrt/irbs/default.htm |
| U.S. Department of Health and Human Services (HHS), home page | http://www.hhs.gov/ |
| NIH, List of bioethics resources on the web | http://www.nih.gov/sigs/bioethics/international.html |
| OTA, Adverse Reactions to HIV Vaccines: Medical, Ethical, and Legal Issues, September 1995, OTA-BP-H-163 | http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1995/9524/9524.PDF |
| POMA, Pharmaceutical Outsourcing Management Association, home page | http://www.pomasite.com/ |
| Research Practicioner Journal, home page | http://www.researchpractice.com/ |
| FDA - Mifepristone Information (home page) | http://www.fda.gov/cder/drug/infopage/mifepristone/ |
| FDA, CDER, New and Generic Drug Approvals: 1998-2001 | http://www.fda.gov/cder/approval/index.htm |
| FDA, Electronic Orange Book - Approved Drug Products with Therapeutic Equivalence Evaluations (query page) | http://www.fda.gov/cder/ob/default.htm |
| United States Patent and Trademark Office - US. PTO | http://www.uspto.gov/ |
| FDA, Warning Letters (home page) | http://www.fda.gov/foi/warning.htm |
| The United States General Accounting Office - home page | http://www.gao.gov/ |
Last updated: January 5, 2002